The preoperative positivity for serum hepatitis B e antigen did not affect overall survival after curative resection of hepatitis B virus-related hepatocellular carcinoma

Journal of Gastroenterology and Hepatology (Australia)

Volumn 24, Issue 3, 2009, Pages 391-398

  Choi, Gi Hong ^a   Kim, Dong Hyun ^a   Choi, Sae Byeol ^a   Kang, Chang Moo ^a   Kim, Kyung Sik ^a   Choi, Jin Sub ^a   Lee, Woo Jung ^a   Han, Kwang Hyub ^a   Chon, Chae Yoon ^a   Kim, Byong Ro ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

Curative resection; Hepatocellular carcinoma; Prognostic factors; Risk factors for intrahepatic recurrence

Indexed keywords

HEPATITIS B(E) ANTIGEN;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER RISK; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; LIVER CELL CARCINOMA; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS;

EID: 63049109007     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2008.05637.x     Document Type: Article

References (33)

1. Shimada K, Sakamoto Y, Esaki M et al. Analysis of prognostic factors affecting survival after initial recurrence and treatment efficacy for recurrence in patients undergoing potentially curative hepatectomy for hepatocellular carcinoma. Ann. Surg. Oncol. 2007 14 : 2319 29.
2. Portolani N, Coniglio A, Ghidoni S et al. Early and late recurrence after liver resection for hepatocellular carcinoma: prognostic and therapeutic implications. Ann. Surg. 2006 243 : 229 35.
3. Poon RT, Fan ST, Lo CM et al. Improving survival results after resection of hepatocellular carcinoma: a prospective study of 377 patients over 10 years. Ann. Surg. 2001 234 : 63 70.
4. Cha C, Fong Y, Jarnagin WR, Blumgart LH, DeMatteo RP. Predictors and patterns of recurrence after resection of hepatocellular carcinoma. J. Am. Coll. Surg. 2003 197 : 753 8.
5. Tung-Ping Poon R, Fan ST, Wong J. Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma. Ann. Surg. 2000 232 : 10 24.
6. Poon RT, Fan ST, Ng IO, Lo CM, Liu CL, Wong J. Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma. Cancer 2000 89 : 500 7.
7. Imamura H, Matsuyama Y, Tanaka E et al. Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy. J. Hepatol. 2003 38 : 200 7.
8. Lee PH, Lin WJ, Tsang YM et al. Clinical management of recurrent hepatocellular carcinoma. Ann. Surg. 1995 222 : 670 6.
9. Poon RT, Fan ST, Lo CM, Liu CL, Wong J. Intrahepatic recurrence after curative resection of hepatocellular carcinoma: long-term results of treatment and prognostic factors. Ann. Surg. 1999 229 : 216 22.
10. Liver Cancer Study Group of Japan. The General Rules for the Clinical and Pathological Study of Primary Liver Cancer, 4th edn. Tokyo : Kanehara, 2000.
11. Choi GH, Kim DH, Kang CM et al. Prognostic factors and optimal treatment strategy for intrahepatic nodular recurrence after curative resection of hepatocellular carcinoma. Ann. Surg. Oncol. 2008 15 : 618 29.
12. Sasaki Y, Yamada T, Tanaka H et al. Risk of recurrence in a long-term follow-up after surgery in 417 patients with hepatitis B- or Hepatitis C-related hepatocellular carcinoma. Ann. Surg. 2006 244 : 771 80.
13. Huang YH, Wu JC, Chen CH et al. Comparison of recurrence after hepatic resection in patients with hepatitis B vs. hepatitis C-related small hepatocellular carcinoma in hepatitis B virus endemic area. Liver Int. 2005 25 : 236 41.
14. Wakai T, Shirai Y, Yokoyama N, Nagakura S, Hatakeyama K. Hepatitis viral status affects the pattern of intrahepatic recurrence after resection for hepatocellular carcinoma. Eur. J. Surg. Oncol. 2003 29 : 266 71.
15. Li Q, Li H, Qin Y, Wang PP, Hao X. Comparison of surgical outcomes for small hepatocellular carcinoma in patients with hepatitis B versus hepatitis C: a Chinese experience. J. Gastroenterol. Hepatol. 2007 22 : 1936 41.
16. Tanaka K, Shimada H, Matsuo K et al. Virus antibody. Ann. Surg. Oncol. 2007 14 : 1170 81.
17. Tsai JF, Jeng JE, Ho MS et al. Additive effect modification of hepatitis B surface antigen and e antigen on the development of hepatocellular carcinoma. Br. J. Cancer 1996 73 : 1498 502.
18. Yang HI, Lu SN, Liaw YF et al. Hepatitis B e antigen and the risk of hepatocellular carcinoma. N. Engl. J. Med. 2002 347 : 168 74.
19. Kubo S, Hirohashi K, Yamazaki O et al. Effect of the presence of hepatitis B e antigen on prognosis after liver resection for hepatocellular carcinoma in patients with chronic hepatitis B. World J. Surg. 2002 26 : 555 60.
20. Sun HC, Zhang W, Qin LX et al. Positive serum hepatitis B e antigen is associated with higher risk of early recurrence and poorer survival in patients after curative resection of hepatitis B-related hepatocellular carcinoma. J. Hepatol. 2007 47 : 684 90.
21. Yamamoto J, Kosuge T, Takayama T et al. Recurrence of hepatocellular carcinoma after surgery. Br. J. Surg. 1996 83 : 1219 22.
22. Shah SA, Greig PD, Gallinger S et al. Factors associated with early recurrence after resection for hepatocellular carcinoma and outcomes. J. Am. Coll. Surg. 2006 202 : 275 83.
23. Park JH, Koh KC, Choi MS et al. Analysis of risk factors associated with early multinodular recurrences after hepatic resection for hepatocellular carcinoma. Am. J. Surg. 2006 192 : 29 33.
24. Shimozawa N, Hanazaki K. Longterm prognosis after hepatic resection for small hepatocellular carcinoma. J. Am. Coll. Surg. 2004 198 : 356 65.
25. Poon RT, Ngan H, Lo CM, Liu CL, Fan ST, Wong J. Transarterial chemoembolization for inoperable hepatocellular carcinoma and postresection intrahepatic recurrence. J. Surg. Oncol. 2000 73 : 109 14.
26. Liovet JM, Schwartz M, Mazzaferro V. Resection and liver transplantation for hepatocellular carcinoma. Semin. Liver Dis. 2005 25 : 181 200.
27. Muto Y, Moriwaki H, Ninomiya M et al. Prevention of second primary tumors by an acyclic retinoid, polyprenoic acid, in patients with hepatocellular carcinoma. Hepatoma Prevention Study Group. N. Engl. J. Med. 1996 334 : 1561 7.
28. Kubo S, Nishiguchi S, Hirohashi K et al. Effects of long-term postoperative interferon-alpha therapy on intrahepatic recurrence after resection of hepatitis C virus-related hepatocellular carcinoma. A randomized, controlled trial. Ann. Inten. Med. 2001 134 : 963 7.
29. Ikeda K, Arase Y, Saitoh S et al. Interferon beta prevents recurrence of hepatocellular carcinoma after complete resection or ablation of the primary tumor-A prospective randomized study of hepatitis C virus-related liver cancer. Hepatology 2000 32 : 228 32.
30. Kubo S, Tanaka H, Takemura S et al. Effects of lamivudine on outcome after liver resection for hepatocellular carcinoma in patients with active replication of hepatitis B virus. Hepatol. Res. 2007 37 : 94 100.
31. Lo CM, Liu CL, Chan SC et al. A randomized, controlled trial of postoperative adjuvant interferon therapy after resection of hepatocellular carcinoma. Ann. Surg. 2007 245 : 831 42.
32. Mazzaferro V, Romito R, Schiavo M et al. Prevention of hepatocellular carcinoma recurrence with alpha-interferon after liver resection in HCV cirrhosis. Hepatology 2006 44 : 1543 54.
33. Kuzuya T, Katano Y, Kumada T et al. Efficacy of antiviral therapy with lamivudine after initial treatment for hepatitis B virus-related hepatocellular carcinoma. J. Gastroenterol. Hepatol. 2007 22 : 1929 35.